Jing Yuan Ma, MD
Cardiovascular Disease · Jackson, MSNPI 1831532746
Payments from drug & device makers
Across 363 payments — averaging $27.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Novartis$1K
- Boehringer Ingelheim$955
- Abiomed$927
- Merck$638
- Boston Scientific$521
- plus $3K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 28 | $2,521 |
| Novartis | 100 | $1,327 |
| Boehringer Ingelheim | 53 | $955 |
| Abiomed | 8 | $927 |
| Merck | 31 | $638 |
| Boston Scientific | 9 | $521 |
| Pfizer | 26 | $433 |
| AstraZeneca | 13 | $359 |
| Johnson & Johnson | 14 | $235 |
| Lantheus Medical Imaging, Inc. | 2 | $220 |
| Edwards Lifesciences | 3 | $213 |
| E.r. Squibb & Sons, L.L.C. | 14 | $210 |
| Actelion Pharmaceuticals US, Inc. | 5 | $150 |
| Regeneron Healthcare Solutions, Inc. | 7 | $136 |
| Novo Nordisk | 6 | $125 |
| Medtronic(2 entities) | 4 | $124 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $105 |
| Amgen | 6 | $93 |
| Lexicon Pharmaceuticals, Inc. | 6 | $85 |
| GE HealthCare | 2 | $64 |
| Sanofi-aventis U.S. LLC | 1 | $59 |
| Heartflow, Inc. | 1 | $52 |
| Alnylam Pharmaceuticals Inc. | 3 | $48 |
| Bayer | 2 | $47 |
| Scpharmaceuticals Inc. | 3 | $44 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $39 |
| Hitachi Healthcare Americas Corp. | 1 | $32 |
| Philips North America LLC | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Bridgebio Pharma, Inc. | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Cvrx, Inc. | 1 | $21 |
| Chiesi USA, Inc. | 1 | $16 |
| Kestra Medical Technology Services, Inc. | 1 | $16 |
| Zimmer Biomet | 1 | $15 |
How this compares
$9,922 in reported general payments places this provider in the 70th percentile of 144 cardiovascular disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Jackson
- James HaysJackson$782K
- Donny StokesJackson$277K
- James HaysJackson$65K
- James BenslerJackson$64K
- Michael HallJackson$54K
- James WarnockJackson$48K
- Tahsin QarqishJackson$39K
- Christopher LatourJackson$33K
- Kenneth MonahanJackson$31K
- Varun SardarJackson$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.